Study S002503

Natriuretic Effect of GLP-1 in Healthy Non Obese Subjects Followed by Oral Sodium Load: A Randomized, Placebo-controlled, Cross-over Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02130778
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: EARLY_PHASE1
Masking: SINGLE
Status: COMPLETED
Enrollment: 15
Start: 2014-04
Primary completion: 2015-10
Lead sponsor: Clinical Hospital Centre Zagreb
Conditions: Sodium Excretion by Urination
Interventions: DRUG:Synthetic GLP-1 (1.5 pmol/kg/min) dissolved in 500 ml 0.9% saline; OTHER:500 ml 0.9% saline
Results posted: FALSE

Registered primary outcomes

Evidence of the positive effect on natriuresis (level of sodium in urin sample) following the of GLP1 infusion [Within the 10 minutes after the infusion synthetic GLP-1 (1.5 pmol/kg/min) dissolved in 500 ml 0.9% saline]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025954	Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study. Baretić M, Diabetes therapy : research, treatment and education of diabetes and related disorders	2018	Randomized trial	PMID 30298444 DOI	cites ClinicalTrials.gov:NCT02130778; registry reference DERIVED:30298444